Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: Hoth Therapeutics

UMB, Isoprene enter into deal with Hoth Therapeutics

The University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc., part of the UM BioPark, announced Wednesday they have entered into a commercial evaluation sublicense and option agreement with Hoth Therapeutics Inc., a development-stage biopharmaceutical company. The agreement grants Hoth complete evaluation and option ...

Read More »